These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 19824075)
21. Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma. Wu X; Yang Y; Xu Z; Li J; Yang B; Feng N; Zhang Y; Wang S Biochim Biophys Acta; 2016 Feb; 1860(2):384-91. PubMed ID: 26116914 [TBL] [Abstract][Full Text] [Related]
22. The expression of Egfl7 in human normal tissues and epithelial tumors. Fan C; Yang LY; Wu F; Tao YM; Liu LS; Zhang JF; He YN; Tang LL; Chen GD; Guo L Int J Biol Markers; 2013 Apr; 28(1):71-83. PubMed ID: 23558933 [TBL] [Abstract][Full Text] [Related]
23. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways. Dai Z; Zhou SL; Zhou ZJ; Bai DS; Xu XY; Fu XT; Chen Q; Zhao YM; Zhu K; Yu L; Yang GH; Wang Z; Wu WZ; Zhou J; Fan J J Pathol; 2014 Nov; 234(3):316-28. PubMed ID: 24962955 [TBL] [Abstract][Full Text] [Related]
24. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma. Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532 [TBL] [Abstract][Full Text] [Related]
25. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
26. DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling. Fu Y; Feng MX; Yu J; Ma MZ; Liu XJ; Li J; Yang XM; Wang YH; Zhang YL; Ao JP; Xue F; Qin W; Gu J; Xia Q; Zhang ZG Oncotarget; 2014 Aug; 5(16):6701-15. PubMed ID: 25149533 [TBL] [Abstract][Full Text] [Related]
27. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression. Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789 [TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways. Massimiani M; Vecchione L; Piccirilli D; Spitalieri P; Amati F; Salvi S; Ferrazzani S; Stuhlmann H; Campagnolo L Mol Hum Reprod; 2015 May; 21(5):435-51. PubMed ID: 25667199 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Wang W; Wu F; Fang F; Tao Y; Yang L Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974 [TBL] [Abstract][Full Text] [Related]
30. FAK is involved in invasion and metastasis of hepatocellular carcinoma. Chen JS; Huang XH; Wang Q; Chen XL; Fu XH; Tan HX; Zhang LJ; Li W; Bi J Clin Exp Metastasis; 2010 Feb; 27(2):71-82. PubMed ID: 20180147 [TBL] [Abstract][Full Text] [Related]
31. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion. Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997 [TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma. Shen X; Han Y; Xue X; Li W; Guo X; Li P; Wang Y; Li D; Zhou J; Zhi Q Biomed Pharmacother; 2016 Feb; 77():167-75. PubMed ID: 26796281 [TBL] [Abstract][Full Text] [Related]
33. Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling. Zhang N; Wang L; Chai ZT; Zhu ZM; Zhu XD; Ma DN; Zhang QB; Zhao YM; Wang M; Ao JY; Ren ZG; Gao DM; Sun HC; Tang ZY PLoS One; 2014; 9(12):e115949. PubMed ID: 25542041 [TBL] [Abstract][Full Text] [Related]
34. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling. Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982 [TBL] [Abstract][Full Text] [Related]
35. Promoting colonization in metastatic HCC cells by modulation of autophagy. Peng YF; Shi YH; Shen YH; Ding ZB; Ke AW; Zhou J; Qiu SJ; Fan J PLoS One; 2013; 8(9):e74407. PubMed ID: 24058558 [TBL] [Abstract][Full Text] [Related]
36. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma. Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858 [TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells. Bai X; Wang J; Zhang L; Ma J; Zhang H; Xia S; Zhang M; Ma X; Guo Y; Rong R; Cheng S; Shu W; Wang Y; Leng J Int J Oncol; 2013 May; 42(5):1833-41. PubMed ID: 23525457 [TBL] [Abstract][Full Text] [Related]
38. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154 [TBL] [Abstract][Full Text] [Related]
40. PRSS8 is Downregulated and Suppresses Tumour Growth and Metastases in Hepatocellular Carcinoma. Zhang L; Jia G; Shi B; Ge G; Duan H; Yang Y Cell Physiol Biochem; 2016; 40(3-4):757-769. PubMed ID: 27915333 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]